Table 1.
Clinical presentations of COVID-19 in asthmatic and non-asthmatic patients
| Clinical Presentation | Asthmatic (n=30) | Non-Asthmatic (n=32) | χ2 | P-value | ||
|---|---|---|---|---|---|---|
|
|
|
|||||
| N | % | N | % | |||
| General (constitutional) | ||||||
| Fever | 22 | 73.3% | 24 | 75.0% | 0.022 | 0.881† |
| Maculopapular skin rash | 0 | 0.0% | 4 | 12.5% | - | 0.114‡ |
| Discolored/Painful extremities | 1 | 3.3% | 3 | 9.4% | - | 0.613‡ |
| Oral ulcers | 1 | 3.3% | 2 | 6.3% | - | >0.999‡ |
| Non-purulent conjunctivitis | 1 | 3.3% | 2 | 6.3% | - | >0.999‡ |
| ENT | ||||||
| Anosmia | 13 | 43.3% | 9 | 28.1% | 1.564 | 0.211† |
| Ageusia | 13 | 43.3% | 9 | 28.1% | 1.564 | 0.211† |
| Sore throat | 11 | 36.7% | 15 | 46.9% | 0.663 | 0.416† |
| GIT | ||||||
| Diarrhea | 6 | 20.0% | 5 | 15.6% | 0.203 | 0.652† |
| Vomiting | 6 | 20.0% | 5 | 15.6% | 0.203 | 0.652† |
| Anorexia | 10 | 33.3% | 9 | 28.1% | 0.198 | 0.657† |
| Abdominal pain | 7 | 23.3% | 8 | 25.0% | 0.023 | 0.878† |
| Circulatory | ||||||
| Hypotension | 2 | 6.7% | 2 | 6.3% | - | >0.999‡ |
| Tachycardia | 5 | 16.7% | 8 | 25.0% | 0.649 | 0.421† |
| Respiratory | ||||||
| Cough | 21 | 70.0% | 15 | 46.9% | 3.401 | 0.065† |
| Expectoration | 11 | 36.7% | 7 | 21.9% | 1.644 | 0.200† |
| Chest pain | 4 | 13.3% | 5 | 15.6% | - | >0.999‡ |
| Dyspnea | 0 | 0.0% | 5 | 15.6% | - | 0.053‡ |
| Tachypnea | 5 | 16.7% | 7 | 21.9% | 0.269 | 0.604† |
| Generalized wheezes | 12 | 40.0% | 2 | 6.3% | 10.089 | 0.001† |
| Rales | 0 | 0.0% | 1 | 3.1% | - | >0.999‡ |
| Decreased air entry | 0 | 0.0% | 1 | 3.1% | - | >0.999‡ |
| Pneumonia | 2 | 6.7% | 2 | 6.3% | - | >0.999‡ |
| Decreased O2 saturation below 92% | 0 | 0.0% | 2 | 6.3% | - | 0.492‡ |
N=number, χ2=chi-squared test.
†
Pearson Chi-squared test.
‡
Fisher’s exact test.